A retention business before it is anything else.
Hair loss has the longest proof cycle in telehealth. A patient will not see a result for three to six months, which means they will decide whether to keep paying long before the therapy has had a chance to work. Every operational decision in this vertical should be aimed at getting them to month six.
- Photo-supported intake for a baseline the patient can compare against
- Compounded topical and oral formulations in one regimen
- Separate male and female protocol lines
- Long refill cycles that match how the regimen is actually used
From first photo to standing refill
The photo at intake is not paperwork. It is the retention asset: at month four the patient cannot see progress in the mirror, but they can see it against their own baseline.
Photo-supported intake
Baseline photographs alongside pattern, duration, family history, medications and consent, giving the provider something to assess and the patient something to compare against.
Asynchronous provider review
A clinician licensed in the patient's state reviews the photos and history and selects a regimen. No appointment at any stage.
Compounded fulfillment
Topical minoxidil and finasteride combinations, oral formulations, or both, from a licensed compounding pharmacy routed to the patient's state.
Refills on the regimen's cadence
Four, twelve and twenty-four week supply options, priced so the longer commitment is the obvious choice for a therapy that needs months to work.
Progress check-ins
Periodic photo check-ins reach the provider, who adjusts the regimen and, just as importantly, tells the patient whether what they are seeing is normal.
Portal that keeps them on protocol
Adherence is the whole game. The portal carries the timeline, the next shipment and the progress comparison under your brand.
Designed around the month-four cliff
Almost all churn in this category happens between month three and month five, when the patient has paid for a while and cannot yet see a difference. That is a product problem, not a marketing one.
- Twelve and twenty-four week supply options priced to make the longer commitment rational.
- Photo comparison in the portal, so progress is visible even when the mirror is not convincing.
- Check-ins that reach the provider, because reassurance from a clinician retains better than an email sequence.
- Separate male and female lines, configured independently, with different formulations and messaging.
- Self-serve card updates, since involuntary churn on a long regimen is pure lost margin.
- Rebills tied to shipment events, so a paused patient is never billed for a shipment that did not go out.
Clinical and regulatory shape of the category
| Visit type | Asynchronous review with photo support. No appointment at any stage. |
|---|---|
| Labs | Not routinely required. Screening is history-based at intake. |
| Refill cadence | Four, twelve or twenty-four week supplies, with periodic photo check-ins to the provider. |
| Scheduling | Minoxidil, finasteride, dutasteride and spironolactone are not controlled substances. |
| Time to visible result | Typically three to six months, which is why retention design matters more here than in any other vertical. |
| Protocol lines | Male and female regimens differ in formulation. Finasteride and dutasteride are male lines; spironolactone appears in female protocols. |
Oversight is wired in, not bolted on
Prescriptions are involved, so clinical oversight is not a setting you switch on. It is wired into the workflow, and there is no configuration in which it is absent.
Provider review the platform enforces
Nothing is prescribed until a clinician holding a licence in that patient's state signs off. There is no path through the software that reaches a pharmacy without it.
State rules in the routing layer
Which questions get asked, which clinician picks up the case and which pharmacy fills it are all decided by where the patient is sitting. Texas and California can run as different programs without you maintaining two of anything.
An audit trail you can query
Every intake version, clinical decision, script and pharmacy handoff is written to the patient record and stays queryable. When someone asks what happened in March, you answer it in a minute.
Hair and skin, answered
No. Asynchronous review with photo support, which keeps acquisition cost low in a category where the payback period is already long.
Launch a hair loss brand built for month six
Photo intake, long supply cycles, and a portal that shows the patient progress they cannot see in the mirror.